中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2015年
1期
44-47,66
,共5页
陈浩%谢宏明%倪江东%宋德业%丁木亮%刘刘
陳浩%謝宏明%倪江東%宋德業%丁木亮%劉劉
진호%사굉명%예강동%송덕업%정목량%류류
慢性肾功能衰竭%血液透析%围术期%全髋关节置换术%并发症
慢性腎功能衰竭%血液透析%圍術期%全髖關節置換術%併髮癥
만성신공능쇠갈%혈액투석%위술기%전관관절치환술%병발증
Chronic renal failure%Hemodialysis%Peri-operative period%Total hip arthroplasty%Complication
目的:评价长期血液透析患者行人工全髋关节置换术的有效性、并发症发生率和早期病死率。方法选择2010年1月~2013年6月于中南大学湘雅二医院行工全髋关节置换术的慢性肾功能衰竭患者19例(21髋)为研究对象,术前平均血透时间为(6.10±2.88)年,术前诊断包括股骨头坏死8例(10髋),髋关节骨性关节炎5例,股骨颈骨折6例,94%的患者存在除肾衰以外的其他一种或多种并存病。术前积极治疗并存病,术前24 h予血透1次,选择合适的假体,在全麻下行全髋关节置换术。临床评估其关节功能、视觉模拟评分(VAS)疼痛评分及影像学复查。登记围术期并发症、远期并发症及死亡事件。结果随访8~43个月,平均(22.4±7.8)个月。术前及术后髋关节Harris评分分别为(32.3±22.8)分和(89.6±8.2)分,差异有统计学意义(P<0.05);术前及术后VAS疼痛评分分别为(5.7±1.7)、(0.7±0.1)分,差异有统计学意义(P<0.05)。早期并发症3例,远期并发症3例,无90 d内死亡病例。结论慢性肾衰合并髋关节病患者行全髋关节置换术可以减轻疼痛,改善关节功能,提高生活质量。但是较高的风险及早期并发症不容忽视。经正确的术前评估和围术期处理,手术相对安全可行。
目的:評價長期血液透析患者行人工全髖關節置換術的有效性、併髮癥髮生率和早期病死率。方法選擇2010年1月~2013年6月于中南大學湘雅二醫院行工全髖關節置換術的慢性腎功能衰竭患者19例(21髖)為研究對象,術前平均血透時間為(6.10±2.88)年,術前診斷包括股骨頭壞死8例(10髖),髖關節骨性關節炎5例,股骨頸骨摺6例,94%的患者存在除腎衰以外的其他一種或多種併存病。術前積極治療併存病,術前24 h予血透1次,選擇閤適的假體,在全痳下行全髖關節置換術。臨床評估其關節功能、視覺模擬評分(VAS)疼痛評分及影像學複查。登記圍術期併髮癥、遠期併髮癥及死亡事件。結果隨訪8~43箇月,平均(22.4±7.8)箇月。術前及術後髖關節Harris評分分彆為(32.3±22.8)分和(89.6±8.2)分,差異有統計學意義(P<0.05);術前及術後VAS疼痛評分分彆為(5.7±1.7)、(0.7±0.1)分,差異有統計學意義(P<0.05)。早期併髮癥3例,遠期併髮癥3例,無90 d內死亡病例。結論慢性腎衰閤併髖關節病患者行全髖關節置換術可以減輕疼痛,改善關節功能,提高生活質量。但是較高的風險及早期併髮癥不容忽視。經正確的術前評估和圍術期處理,手術相對安全可行。
목적:평개장기혈액투석환자행인공전관관절치환술적유효성、병발증발생솔화조기병사솔。방법선택2010년1월~2013년6월우중남대학상아이의원행공전관관절치환술적만성신공능쇠갈환자19례(21관)위연구대상,술전평균혈투시간위(6.10±2.88)년,술전진단포괄고골두배사8례(10관),관관절골성관절염5례,고골경골절6례,94%적환자존재제신쇠이외적기타일충혹다충병존병。술전적겁치료병존병,술전24 h여혈투1차,선택합괄적가체,재전마하행전관관절치환술。림상평고기관절공능、시각모의평분(VAS)동통평분급영상학복사。등기위술기병발증、원기병발증급사망사건。결과수방8~43개월,평균(22.4±7.8)개월。술전급술후관관절Harris평분분별위(32.3±22.8)분화(89.6±8.2)분,차이유통계학의의(P<0.05);술전급술후VAS동통평분분별위(5.7±1.7)、(0.7±0.1)분,차이유통계학의의(P<0.05)。조기병발증3례,원기병발증3례,무90 d내사망병례。결론만성신쇠합병관관절병환자행전관관절치환술가이감경동통,개선관절공능,제고생활질량。단시교고적풍험급조기병발증불용홀시。경정학적술전평고화위술기처리,수술상대안전가행。
Objective To evaluate the effectiveness, complication rate and early mortality of total hip arthroplasty in patients with long-term hemodialysis. Methods 19 patients (21 hips) with hemodialysis who were preformed total hip arthroplasty in the Second Xiangya Hospital of Central South University from January 2010 to June 2013 were enrolled. The mean duration of hemodialysis before operation was (6.10±2.88) years;indications included osteonecrosis of femoral head (8 patients, 10 hips), osteoarthritis (5 patients) and femoral neck fracture (6 patients); 94% of the patients com-bined with one or more comorbidities. All comorbidities were treated actively and each patient received hemodialysis within 24 hours before operation. The surgery was carried out under general anesthesia using proper prosthesis. All pa-tients were proceeded hemodialysis without heparin for 1 day after surgery. The clinical outcome was assessed using the Harris hip score, VAS for pain and radiography. Early and long-term complications and mortality were record. Results All patients were followed up 8 to 43 months, average (22.4±7.8) months. The preoperative and postoperative Harris hip score were (32.3±22.8) points and (89.6±8.2) points respectively, the difference was statistically significant (P< 0.05);the preoperative and postoperative VAS for pain were (5.7±1.7) points and (0.7±0.1) points respectively, the difference was statistically significant (P < 0.05). 3 cases of early complications and 3 cases of long-term complications were record; no patient died within 90 days. Conclusion For the dialysis population suffered from severe hip diseases, total hip arthroplasty may substantially release pain, improve the function of hip and the quality of life. However, high risks and complication rate should not be neglected. Proper preoperative evaluation and perioperative management are cru-cial elements to make the surgery relatively safer.